Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial, Malaria Journal, vol.8, issue.1, p.141, 2009. ,
DOI : 10.1186/1475-2875-8-141
Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates, J. Clin. Microbiol, vol.36, pp.243-247, 1998. ,
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.5, pp.537-544, 2000. ,
DOI : 10.1016/S0035-9203(00)90080-4
A Molecular Marker for Chloroquine-Resistant Falciparum Malaria, New England Journal of Medicine, vol.344, issue.4, pp.257-263, 2001. ,
DOI : 10.1056/NEJM200101253440403
Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009. ,
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique, Malaria Journal, vol.7, issue.1, p.115, 2002. ,
DOI : 10.1186/1475-2875-7-115
Antimalarial drug discovery: efficacy models for compound screening, Nature Reviews Drug Discovery, vol.91, issue.6, pp.509-520, 2004. ,
DOI : 10.1038/nrd1416
Novel point mutations in sulfadoxine resistance genes of Plasmodium falciparum from India, Acta Tropica, vol.110, issue.1, pp.75-79, 2009. ,
DOI : 10.1016/j.actatropica.2009.01.009
The Limits and Intensity of Plasmodium falciparum Transmission: Implications for Malaria Control and Elimination Worldwide, PLoS Medicine, vol.3, issue.2, p.38, 2008. ,
DOI : 10.1371/journal.pmed.0050038.st001
Malaria, The Journal of Infectious Diseases, vol.185, issue.3, pp.380-388, 2002. ,
DOI : 10.1086/338566
Malaria after Cessation of Chloroquine Use in Malawi, The Journal of Infectious Diseases, vol.187, issue.12, pp.1870-1875, 2003. ,
DOI : 10.1086/375419
Return of Chloroquine Antimalarial Efficacy in Malawi, New England Journal of Medicine, vol.355, issue.19, pp.1959-1966, 2006. ,
DOI : 10.1056/NEJMoa062032
Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi, Am. J. Trop. Med. Hyg, vol.68, pp.413-415, 2003. ,
Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea, Infection, Genetics and Evolution, vol.6, issue.6, pp.447-452, 2006. ,
DOI : 10.1016/j.meegid.2006.02.004
Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia, Clinical Infectious Diseases, vol.51, issue.11, pp.82-89, 2010. ,
DOI : 10.1086/657120
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study, The Lancet, vol.356, issue.9226, pp.297-302, 2000. ,
DOI : 10.1016/S0140-6736(00)02505-8
Drug Resistance Hampers Our Capacity to Roll Back Malaria, Clinical Infectious Diseases, vol.41, issue.s4, pp.247-257, 2005. ,
DOI : 10.1086/430785
Dihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine???Sulfadoxine Use and Resistance, The Journal of Infectious Diseases, vol.176, issue.6, pp.1590-1596, 1997. ,
DOI : 10.1086/514159
malaria in Iran, Annals of Tropical Medicine & Parasitology, vol.2, issue.1, pp.11-16, 2006. ,
DOI : 10.1086/375250
URL : https://hal.archives-ouvertes.fr/pasteur-00750766
Five Years of Large-Scale dhfr and dhps Mutation Surveillance Following the Phased Implementation of Artesunate Plus Sulfadoxine-Pyrimethamine in Maputo Province, Southern Mozambique, American Journal of Tropical Medicine and Hygiene, vol.82, issue.5, pp.788-794, 2010. ,
DOI : 10.4269/ajtmh.2010.09-0401
High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction, Molecular and Biochemical Parasitology, vol.61, issue.2, pp.315-320, 1993. ,
DOI : 10.1016/0166-6851(93)90077-B
The global distribution of clinical episodes of Plasmodium falciparum malaria, Nature, vol.3, issue.7030, pp.214-217, 2004. ,
DOI : 10.1016/S0169-4758(98)01296-4
Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda, Tropical Medicine and International Health, vol.41, issue.5, pp.624-629, 2004. ,
DOI : 10.1046/j.1365-3156.2001.00751.x
Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria, The EMBO Journal, vol.17, issue.14, pp.3807-3815, 1998. ,
DOI : 10.1093/emboj/17.14.3807
The mechanism of resistance to sulfa drugs in Plasmodium falciparum, Drug Resistance Updates, vol.2, issue.1, pp.15-19, 1999. ,
DOI : 10.1054/drup.1998.0060
Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran, Acta Tropica, vol.97, issue.3, pp.352-356, 2006. ,
DOI : 10.1016/j.actatropica.2006.01.002
Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China, Am. J. Trop. Med. Hyg, vol.72, pp.410-414, 2005. ,
Monitoring Antimalarial Drug Resistance, World Health Organization, vol.17, p.39, 2002. ,
Mutations at Codons 108 and 59 in the Sistan???Baluchistan Province, Iran, The Journal of Infectious Diseases, vol.187, issue.11, pp.1828-1829, 2003. ,
DOI : 10.1086/375250
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran, Malaria Journal, vol.6, issue.1, p.148, 2007. ,
DOI : 10.1186/1475-2875-6-148
Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum, Am. J. Trop. Med. Hyg, vol.78, pp.633-640, 2008. ,
High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine???pyrimethamine, International Journal of Infectious Diseases, vol.14, pp.123-128, 2010. ,
DOI : 10.1016/j.ijid.2009.11.035